➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts
Medtronic
Dow
AstraZeneca

Last Updated: July 31, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GEVOKIZUMAB


Email this page to a colleague

« Back to Dashboard

Clinical Trials for Gevokizumab

Trial ID Title Status Sponsor Phase Summary
NCT01498874 ↗ Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris Completed XOMA (US) LLC Phase 2 The purpose of this study is to determine whether gevokizumab is effective in the treatment of moderate to severe acne vulgaris.
NCT01683396 ↗ Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand Completed XOMA (US) LLC Phase 2 The purpose of this proof-of-concept study is to determine whether gevokizumab is effective in the treatment of active inflammatory, erosive osteoarthritis of the hand.
NCT01684345 ↗ Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis Terminated Institut de Recherches Internationales Servier Phase 3 The purpose of this study is to evaluate the efficacy of gevokizumab in the treatment of active non-infectious intermediate, posterior, or pan- uveitis.
NCT01684345 ↗ Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis Terminated XOMA (US) LLC Phase 3 The purpose of this study is to evaluate the efficacy of gevokizumab in the treatment of active non-infectious intermediate, posterior, or pan- uveitis.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Gevokizumab

Condition Name

Condition Name for
Intervention Trials
Pyoderma Gangrenosum 4
Osteoarthritis 3
Uveitis 3
Autoimmune Inner Ear Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Uveitis 5
Pyoderma Gangrenosum 4
Pyoderma 4
Osteoarthritis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Gevokizumab

Trials by Country

Trials by Country for
Location Trials
United States 191
Australia 14
Argentina 6
United Kingdom 5
Canada 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
Texas 11
North Carolina 11
Florida 10
California 10
Pennsylvania 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Gevokizumab

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 8
Phase 2 5
Phase 1 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Terminated 8
Completed 6
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Gevokizumab

Sponsor Name

Sponsor Name for
Sponsor Trials
XOMA (US) LLC 13
Institut de Recherches Internationales Servier 2
Servier 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 15
Other 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Baxter
Johnson and Johnson
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.